Skip to content
Research use only · not for human or veterinary consumption 10 slots open →
Tesamorelin 2mg lyophilised research vial, 99% purity

Specification

Purity>99% (HPLC + MS)
FormLyophilised powder
Supplied asSingle sealed vial
Storage-20 °C, dark, sealed
Reconstituted2–8 °C

Certificate of analysis

Scan the QR code on your vial, or type the batch number, and you get the analytical data for the exact vial you received.

Verify your vial →

Tesamorelin

TH9507, trans-3-hexenoyl-GHRH(1-44)

A stabilised GHRH(1-44) analog and the only GH-axis compound with regulatory approval specifically for reducing visceral adipose tissue.

Research use only. This compound is supplied for laboratory research. It is not a medicine or supplement, is not approved for human use, and no dosing guidance for humans is offered here or by our team. Handle under appropriate laboratory conditions. Full disclaimer →

What the literature describes

Tesamorelin is a synthetic analogue of human growth hormone-releasing hormone modified with a trans-3-hexenoyl group at the N-terminus to resist DPP-4 degradation. Across two 26-week phase 3 trials in HIV-associated central fat accumulation it significantly reduced waist circumference and visceral adipose tissue — roughly an 18% VAT reduction — without a clinically significant effect on subcutaneous adipose tissue. Later randomised work reported reductions in liver fat. It remains the reference compound in the literature for selective visceral fat research.

Available sizes & pricing

Price is per single sealed vial, in USD. Buying several — volume pricing.

Vial strengthPrice
2mg $117.60 Order 2mg
5mg $221.20 Order 5mg
10mg $417.20 Order 10mg
20mg $719.60 Order 20mg

Published research

Links open peer-reviewed sources on PubMed. These are provided so you can read the primary literature yourself. Citing a study is not a claim that this compound is safe or effective for any use in humans.

Research areas

Studied in the same area

Retatrutide 5mg lyophilised research vial, 99% purity

Retatrutide

LY3437943, triple GIP/GLP-1/glucagon receptor agonist

A single-molecule triple agonist at the GIP, GLP-1 and glucagon receptors — the most-discussed metabolic research peptide of the current cycle.

5mg10mg15mg20mg30mg50mg+1
$75 from, per vial View
Tirzepatide 5mg lyophilised research vial, 99% purity

Tirzepatide

LY3298176, dual GIP/GLP-1 receptor agonist

A unimolecular dual agonist of the GIP and GLP-1 receptors, and the compound behind the SURMOUNT and SURPASS trial programmes.

2mg5mg10mg15mg20mg30mg+5
$46 from, per vial View
CJC-1295 (no DAC) 5mg + Ipamorelin 5mg 10mg lyophilised research vial, 99% purity

CJC-1295 (no DAC) 5mg + Ipamorelin 5mg

Mod GRF (1-29) + Ipamorelin blend

The classic paired blend: a GHRH analog alongside a selective ghrelin-receptor agonist, studied for complementary action on the GH axis.

10mg
$187.60 from, per vial View
MOTS-c 10mg lyophilised research vial, 99% purity

MOTS-c

Mitochondrial ORF of the 12S rRNA type-c

A 16-amino-acid peptide encoded in mitochondrial DNA rather than the nuclear genome — a mitochondrial-derived peptide studied as an exercise mimetic.

10mg40mg
$151.20 from, per vial View